Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 0.125% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) Cc1ccc(S(=O)(=O)CCC(=O)OCC(=O)NCCc2ccccc2)cc1
(b) FC(F)(F)c1cccc(OCC2CNC(=S)O2)c1
(c) O=C(CN1C(=O)c2ccccc2S1(=O)=O)NCCSc1ccccc1
Answer: b. FC(F)(F)c1cccc(OCC2CNC(=S)O2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
FC(F)(F)c1cccc(OCC2CNC(=S)O2)c1
FC(F)(F)c1cccc(OCC2CNC(=S)O2)c1
5-[[3-(trifluoromethyl)phenoxy]methyl]-1,3-oxazolidine-2-thione